DRUG · Mapped RxNorm record
imatinib mesylate
Normalized identity: imatinib mesylateView linked drug · Find medicine records ·
Find other trials using this name
Clinical trial
Imatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
NCT00090987
Drugs and interventions used in this trial
1 registeredThese interventions are listed by ClinicalTrials.gov. An RxNorm link indicates a mapped medicine record; the registry name alone is not proof of a specific branded formulation.
No matching interventions in this trial.
Study at a glance
Registry-backedImatinib Mesylate in Treating Patients With HIV-Related Kaposi's Sarcoma
Design: INTERVENTIONAL · Status: COMPLETED · Phase: PHASE2
Read study objectives, eligibility and outcome measures at ClinicalTrials.govAdvertisement
Conditions
Sarcomaverified · MONDO: sarcoma
Interventions
imatinib mesylateDRUG · verified · RxNorm: imatinib mesylate
Sponsors & collaborators
AIDS Malignancy Consortiumlead sponsor
National Cancer Institute (NCI)collaborator
The Emmes Company, LLCcollaborator
Mapped research locations
Los AngelesCalifornia, United States2New YorkNew York, United States1BostonMassachusetts, United States1ChicagoIllinois, United States1PhiladelphiaPennsylvania, United States1BaltimoreMaryland, United States1St LouisMissouri, United States1MiamiFlorida, United States1San FranciscoCalifornia, United States1SeattleWashington, United States1ClevelandOhio, United States1The BronxNew York, United States1
Registry source
Open the source record to verify current eligibility, contacts, locations and registry updates.
Open NCT00090987 on ClinicalTrials.gov ↗Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.